CTRI/2019/09/021317已完成未知
Evaluation of genotyping and therapeutic drug monitoring vs. only therapeutic drug monitoring as a strategy for risk minimization in epileptic patients on phenytoin therapy: a randomized controlled trial
Dr Nithya Gogtay0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i) Patients diagnosed with epilepsy ii) Patients on phenytoin therapy for at least 3 months duration
- •iii) Patients complaining of any ADRs to phenytoin like giddiness, headache, etc.
排除标准
- •i) Patients with epilepsy on phenytoin therapy and are not willing to participate in the study
- •ii) Genotype (CYP2C9 and CYP2C19 polymorphism) results known to participant from prior testing or available in medical record
- •iii) Patients with neurological deficits
- •iv) Patients with history of drug /alcohol abuse
研究者
相似试验
已完成
不适用
Genotyping and TDM in Epileptic patients on CBZ : RCTCTRI/2019/09/021311Dr Nithya Gogtay50
招募中
不适用
Evaluation of the effect of the genetic polymorphism of drug metabolizing enzyme/transporter and drug interaction on the pharmacokinetics and pharmacodynamics of clopidogrelKCT0000429Seoul National University18
招募中
4 期
Whether medical treatment based on genetic testing has any impact of the bleeding and treatment costs when compared to usual care without genetic testingCTRI/2019/06/019648Dr Akash Shukla
尚未招募
不适用
Clinical utility of genetic testing based treatment of depression in India as per recommendations of international guidelinesCTRI/2022/08/044982Indian Council of Medical Research
尚未招募
不适用
A study to analyze genetic polymorphism of drug metabolizing enzymes using blood samples in Korean populatioKCT0003406Kyung Hee University Hospital150